research use only
Cat.No.S8603
| Related Targets | HDAC Caspase Proteasome MMP HCV Protease Cysteine Protease Tyrosinase DPP HIV Protease Serine Protease |
|---|---|
| Other Secretase Inhibitors | DAPT RO4929097 (RG-4733) LY411575 Nirogacestat (PF-03084014) Dibenzazepine (YO-01027) MK-0752 Semagacestat (LY450139) Avagacestat (BMS-708163) MDL-28170 L-685,458 |
|
In vitro |
DMSO
: 40 mg/mL
(98.39 mM)
Ethanol : 3 mg/mL Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 406.52 | Formula | C23H23FN4S |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 1304630-27-0 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | CCC1=CC(=C(C=C1C)C)NC2=NC(=CS2)C3=CC(=C(C=C3)N4C=C(N=C4)C)F | ||
| Targets/IC50/Ki |
γ secretase
(Cell-free assay) |
|---|---|
| In vivo |
NGP 555 has very good brain penetration/absorption, distribution, metabolism, and excretion (ADME) properties. It efficiently crosses the blood-brain barrier, has a brain:plasma ratio of 0.93 (in Tg2576 mice) and shows in vivo efficacy for lowering the biomarker Aβ42 in rodent studies for brain and plasma. Chronic administration of this compound (milled into chow) to Tg2576 mice results in a significant reduction of amyloid plaques.
|
References |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.